Logo Lucerna-Chem
+41 41 420 9636

Article Status


SRX3207


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-136198-5MG 5 mg 477,00 405,50 Add
HY-136198-10MG 10 mg 810,00 688,50 Add
HY-136198-25MG 25 mg 1'485,00 1'262,30 Add
HY-136198-50MG 50 mg 2'419,00 2'056,20 Add
HY-136198-100MG 100 mg 3'737,00 3'176,50 Add

* CHF, excl. 7.7% VAT and shipping costs


Product Description

SRX3207 is an orally active and first-in-class dual Syk/PI3K inhibitor, with IC50 values of 10.7 nM and 861 nM for Syk and PI3Kα, respectively. SRX3207 relieves tumor immunosuppression.

Category Biochemicals
Supplier MedChem Express
Application Cancer-Kinase/protease
Regulatory Status RUO
Format Solubility: DMSO : 5 mg/mL (9.00 mM; Need ultrasonic)
Grade Clinical information: No Development Reported
Purity 98.5%
Molecular Formula C29H29N7O3S
Molecular Weight 555.65
CAS-Number [2254693-15-5]
Storage Conditions Powder -20°C 3 years, 4°C 2 years; In solvent -80°C 6 months, -20°C 1 month
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland